Cikarang Listrindo Tbk PT
IDX:POWR
Cikarang Listrindo Tbk PT
IDX:POWR
Price:
725
IDR
Market Closed
Market Cap:
Rp11.7T
Balance Sheet
Balance Sheet Decomposition
Cikarang Listrindo Tbk PT
Cikarang Listrindo Tbk PT
Balance Sheet Decomposition is not available for
Cikarang Listrindo Tbk PT
Cikarang Listrindo Tbk PT
Balance Sheet
Cikarang Listrindo Tbk PT
Cikarang Listrindo Tbk PT
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
52
|
91
|
58
|
151
|
94
|
122
|
36
|
101
|
278
|
305
|
244
|
191
|
|
| Cash |
52
|
91
|
58
|
151
|
94
|
122
|
36
|
101
|
44
|
91
|
138
|
67
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
234
|
214
|
106
|
125
|
|
| Short-Term Investments |
92
|
6
|
0
|
71
|
104
|
106
|
214
|
232
|
112
|
111
|
176
|
253
|
|
| Total Receivables |
59
|
70
|
71
|
66
|
71
|
71
|
74
|
59
|
57
|
59
|
62
|
62
|
|
| Accounts Receivables |
59
|
61
|
71
|
66
|
70
|
70
|
73
|
58
|
57
|
57
|
59
|
54
|
|
| Other Receivables |
1
|
10
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
8
|
|
| Inventory |
25
|
26
|
24
|
33
|
32
|
43
|
43
|
43
|
47
|
63
|
69
|
64
|
|
| Other Current Assets |
37
|
29
|
13
|
5
|
6
|
6
|
5
|
3
|
2
|
3
|
5
|
5
|
|
| Total Current Assets |
265
|
223
|
165
|
326
|
308
|
348
|
372
|
437
|
497
|
542
|
556
|
576
|
|
| PP&E Net |
551
|
675
|
811
|
889
|
938
|
908
|
867
|
836
|
797
|
783
|
751
|
739
|
|
| PP&E Gross |
551
|
675
|
811
|
889
|
938
|
908
|
867
|
836
|
797
|
783
|
751
|
739
|
|
| Accumulated Depreciation |
483
|
524
|
564
|
603
|
643
|
701
|
760
|
813
|
867
|
920
|
975
|
1 032
|
|
| Note Receivable |
10
|
0
|
25
|
2
|
16
|
15
|
45
|
39
|
40
|
25
|
6
|
12
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
12
|
11
|
11
|
11
|
10
|
10
|
10
|
9
|
|
| Other Long-Term Assets |
7
|
4
|
4
|
53
|
49
|
26
|
30
|
19
|
15
|
1
|
1
|
1
|
|
| Total Assets |
834
N/A
|
902
+8%
|
1 006
+11%
|
1 271
+26%
|
1 323
+4%
|
1 309
-1%
|
1 325
+1%
|
1 343
+1%
|
1 359
+1%
|
1 362
+0%
|
1 324
-3%
|
1 337
+1%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
21
|
26
|
38
|
32
|
41
|
34
|
34
|
24
|
30
|
33
|
33
|
34
|
|
| Accrued Liabilities |
14
|
14
|
14
|
11
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
7
|
24
|
32
|
22
|
27
|
20
|
13
|
22
|
13
|
11
|
15
|
11
|
|
| Total Current Liabilities |
42
|
64
|
85
|
65
|
77
|
63
|
56
|
56
|
54
|
55
|
58
|
54
|
|
| Long-Term Debt |
493
|
494
|
498
|
538
|
538
|
539
|
540
|
543
|
544
|
546
|
499
|
500
|
|
| Deferred Income Tax |
28
|
0
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
13
|
|
| Other Liabilities |
48
|
58
|
61
|
64
|
69
|
67
|
70
|
73
|
63
|
55
|
59
|
62
|
|
| Total Liabilities |
611
N/A
|
639
+5%
|
669
+5%
|
667
0%
|
683
+2%
|
669
-2%
|
665
-1%
|
672
+1%
|
660
-2%
|
662
+0%
|
620
-6%
|
629
+1%
|
|
| Equity | |||||||||||||
| Common Stock |
121
|
121
|
258
|
282
|
282
|
282
|
282
|
282
|
282
|
282
|
282
|
282
|
|
| Retained Earnings |
102
|
142
|
79
|
174
|
210
|
212
|
249
|
261
|
288
|
293
|
295
|
299
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
148
|
148
|
148
|
148
|
148
|
148
|
148
|
147
|
147
|
|
| Unrealized Security Profit/Loss |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
3
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
1
|
20
|
20
|
20
|
19
|
17
|
16
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
223
N/A
|
263
+18%
|
337
+28%
|
604
+79%
|
640
+6%
|
640
+0%
|
660
+3%
|
671
+2%
|
698
+4%
|
700
+0%
|
704
+1%
|
708
+1%
|
|
| Total Liabilities & Equity |
834
N/A
|
902
+8%
|
1 006
+11%
|
1 271
+26%
|
1 323
+4%
|
1 309
-1%
|
1 325
+1%
|
1 343
+1%
|
1 359
+1%
|
1 362
+0%
|
1 324
-3%
|
1 337
+1%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
5 340
|
5 340
|
14 478
|
16 087
|
16 087
|
16 069
|
15 781
|
15 758
|
15 770
|
15 784
|
15 806
|
15 830
|
|
Switch to:
Switch to:
See Also
Discover More
